Mahesh Kumar
Dr. Mahesh Kumar is the Senior Vice President of Global Biologics Research and Development at Zoetis, a leading animal health company. He has been instrumental in the development of vaccines for avian influenza, including the recent H5N2 vaccine that received a conditional license from the USDA. With over two decades of experience in veterinary medicine and vaccine development, Kumar has played a key role in addressing outbreaks affecting poultry and ensuring the health of animal populations.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Nepal | 1 | 2.00 | 0.14% | +0% | 29,136,808 | 42,227 | $34,000 | 49$ |
| Totals | 1 | 29,136,808 | 42,227 | $34,000 | 49$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Nepal:
Mahesh Kumar admitted to threatening the public and committing theft.
2
Pakistan:
Dr. Mahesh Kumar, a member of the National Assembly, demanded the collection of data on qualified doctors in the public and private sectors.
7
India:
ADCP South Mahesh Kumar instructed the officials to register a case.
7
Hong Kong:
Mahesh Kumar, an IT consultant from Texas, described the fear experienced by passengers during the bomb threat incident.
7
United States:
Mahesh Kumar, Ph.D., senior vice president, global biologics research and development at Zoetis, stated that their scientists immediately began work to update their previous avian influenza vaccine.
8